Last reviewed · How we verify

NCT06367543: NORMONICU

Guideline-recommended Basic Parameter Adherence in Neurocritical Care Patients

Completed Last updated 6 April 2025
What this trial tests

trial testing Time in therapeutic range of vital parameters in Stroke in 474 participants. Completed in 31 December 2021.

Timeline
1 January 2021
Primary endpoint
31 December 2021
31 December 2021

Quick facts

Lead sponsorUniversity of Giessen
StatusCompleted
Study typeOBSERVATIONAL
Enrollment474
Start date1 January 2021
Primary completion31 December 2021
Estimated completion31 December 2021
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

University of Giessen

Who can join

18 and older, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the planned study project is to assess the current situation regarding the treatment of patients with severe stroke at the neuro-critical care unit. Specifically, determination of whether the target parameters recommended in the guidelines for temperature, systolic blood pressure, mean arterial blood pressure, blood glucose, arterial oxygen partial pressure and arterial carbon dioxide partial pressure had to be maintained. From the planned data analysis, the need for the introduction of cerebrovascular bundles can be derived and planned.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other University of Giessen trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06367543.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing